management of diabetes type i
TRANSCRIPT
-
7/31/2019 Management of Diabetes Type i
1/11
MANAGEMENT OF DIABETES
TYPE I:
-
7/31/2019 Management of Diabetes Type i
2/11
Proper therapy involves integration of
i.insulin therapy
ii.dietary management
iii physical exercise & fitness
iv.emotional &social support in order toprevent the onset of acute & chroniccompications.
-
7/31/2019 Management of Diabetes Type i
3/11
PRINCIPLES OF DIABETES MANAGEMENT:
1.elimination of clinical features of uncontrolled
diabetes.
2. prevention of DKA.
3. avoidance of hypoglycemia. 4. maintenance of normal growth & maturation.
5. early detection of associated diseases.
6. prevention of emotional disorders.
7. prevetion of chronic vascular complications ofdiabetes.
-
7/31/2019 Management of Diabetes Type i
4/11
Type of Insulin& Brand NamesOnset Peak
Duration
Role in BloodSugarManagement
Rapid-ActingHumalog orlispro
15-30min. 30-90 min
3-5hours
Rapid-acting insulin
covers insulin needs
for meals eaten at
the same time as
the injection. This
type of insulin is
used with longer-
acting insulin.
Novolog oraspart
10-20min. 40-50 min.
3-5hours
Apidra orglulisine
20-30min. 30-90 min.
1-2hours
-
7/31/2019 Management of Diabetes Type i
5/11
Short-Acting
Regular (R)humulin or novolin
30 min. -1hour 2-5 hours 5-8 hours
Short-acting insulincovers insulinneeds for mealseaten within 30-60
minutesVelosulin (for usein the insulinpump)
30 min.-1hour 2-3 hours 2-3 hours
Intermediate-Acting
NPH (N) 1-2 hours 4-12 hours 18-24hours Intermediate-actinginsulin coversinsulin needs forabout half the dayor overnight. Thistype of insulin isoften combinedwith rapid- orshort-acting insulin.
Lente (L) 1-2 hours 3-10 hours 18-24hours
-
7/31/2019 Management of Diabetes Type i
6/11
Long-Acting
Ultralente (U)30 min.-3 hours 10-20 hours
20-36hours
Long-acting insulin
covers insulin
needs for about
one full day. This
type of insulin isoften combined,
when needed,
with rapid- or
short-acting
insulin.
Lantus 1-1hour
No peak time;
insulin isdelivered at asteady level 20-24hours
Levemir ordetemir
1-2hours 6-8 hours
Up to24hours
-
7/31/2019 Management of Diabetes Type i
7/11
Pre-Mixed*
Humulin 70/30 30 min. 2-4 hours 14-24hours
These products
are generally
taken twice a
day before
mealtime.
Novolin 70/30 30 min. 2-12 hoursUp to24hours
Novolog 70/30 10-20
min.1-4 hours
Up to24hours
Humulin 50/50 30 min. 2-5 hours 18-24hours
Humalog mix75/25 15 min. 30 min.-2 hours 16-20hours
*Premixed insulins are a combination of specific proportions of
intermediate-acting and short-acting insulin in one bottle or
insulin pen (the numbers following the brand name indicate the
percentage of each type of insulin).
-
7/31/2019 Management of Diabetes Type i
8/11
DIABETICKETOACIDOSIS
People with type 1 diabetes do not have enoughinsulin, a hormone the body uses to break downsugar (glucose) in the blood for energy. Whenglucose is not available, fat is broken down instead.
As fats are broken down, acids called ketones buildup in the blood and urine. In high levels, ketonesare poisonous. This condition is known asketoacidosis.
Blood glucose levels rise (usually higher than 300mg/dL) because the liver makes glucose to try tocombat the problem. However the cells cannot pullin that glucose without insulin
http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A000305/http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A003482/http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A003482/http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A000305/ -
7/31/2019 Management of Diabetes Type i
9/11
TREATMENT
Insulin replacement
Fluid and electrolyte replacement
http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A002350/http://www.ncbi.nlm.nih.gov/pubmedhealth/n/pmh_adam/A002350/ -
7/31/2019 Management of Diabetes Type i
10/11
Comparison of type 1 and 2 diabetes
Feature Type 1 diabetes Type 2 diabetes
Onset&diagnosis Sudden;peak age:11-12yrs;diagnosed before 20 yrsGradual;diagnosed after 40yrs
Age at onsetMostly in Children (days orweeks);insulin levels low or
nonexistent
Mostly in adults.insulinlevels may be normal,mild
elevated or depressed
EtiologyCirculating islet cellantibodies presentunknown,butgenetic,viralor autoimmunefactors
No Circulating islet cell
antibodiesUnknown,but genetic &envt.factors areimportant.;riskfactos:obesity
-
7/31/2019 Management of Diabetes Type i
11/11
Management
Dependent on insulin toprevent ketoacidosis &sustain life
Insulin,diet(mealplanning) &exercise
Not Dependent on insulinto sustain life & notprone for ketoacidosis
Insulin may requiredtemporarily for Periods ofstress like:
surgery,trauma,orinfection
diet(mealplanning)&exercise,occassionaly oralhypoglycemicagents&/insulin
Body habitus Thin or normal Often obese
Ketoacidosis Common Rare
Autoantibodies Usually present Absent
Endogenous insulin Low or absent Normal, decreasedor increased
Concordancein identical twins 50% 90%
Prevalence ~10-20% ~80-90%
PreventionNone known,but futureresearch may clarifyetiology
Even small weight lossesmay return plasmaglucoseto normal in many
pts with this type
http://en.wikipedia.org/wiki/Diabetic_ketoacidosishttp://en.wikipedia.org/wiki/Autoantibodieshttp://en.wikipedia.org/wiki/Autoantibodieshttp://en.wikipedia.org/wiki/Identical_twinhttp://en.wikipedia.org/wiki/Identical_twinhttp://en.wikipedia.org/wiki/Identical_twinhttp://en.wikipedia.org/wiki/Concordance_(genetics)http://en.wikipedia.org/wiki/Autoantibodieshttp://en.wikipedia.org/wiki/Diabetic_ketoacidosishttp://en.wikipedia.org/wiki/Obese